Filter
825
Text search:
childbearing
Featured
62
287
Language
Document type
591
100
73
20
18
8
6
5
3
1
Countries / Regions
51
35
31
31
31
28
27
25
23
23
20
19
19
18
17
15
14
14
13
11
10
10
9
9
8
8
8
7
7
6
5
5
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
503
75
62
35
30
12
2
Toolboxes
78
29
24
19
15
14
14
13
11
11
10
8
8
7
7
6
2
1
1
1
1
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Washington (DC): National Academies Press (US); 2001.
Position Statement
Diabetes Care2018;42(Suppl. 1):S1–S194.
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Mood disorders
Chapter E.1
2015 edition
Original research article
Contraception 97 (2018) 439–444
https://doi.org/10.1016/j.contraception.2018.01.003
0010-7824/© 2018 The Authors. Published by Elsevier Inc.
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
Mortality and burden of disease attributable to selected major risks
Olashore et al.
Child Adolesc Psychiatry Ment Health (2017) 11:8 DOI 10.1186/s13034-017-0144-9
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
PLoS Med. 2009 Oct;6(10):e1000159. doi: 10.1371/journal.pmed.1000159. Epub 2009 Oct 6.
The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards the goals, targets and milestones of the GTS. The central pillar of the framework is the adoption of programme phasing and transitioning, aimed at facilitating a tailored approac
...
